|Institutional Source||Beutler Lab|
|Gene Name||SLIT and NTRK-like family, member 5|
Ncbi RefSeq: NM_198865.1; MGI:2679448
|Essential gene?||Possibly essential (E-score: 0.710)|
|Stock #||R1754 (G1)|
|Chromosomal Location||111675097-111683141 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to C at 111680519 bp (GRCm38)|
|Amino Acid Change||Phenylalanine to Serine at position 525 (F525S)|
|Ref Sequence||ENSEMBL: ENSMUSP00000041499 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000042767] [ENSMUST00000227891]|
AA Change: F525S
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: F525S
|Coding Region Coverage||
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Members of the SLITRK family, such as SLITRK5, are integral membrane proteins with 2 N-terminal leucine-rich repeat (LRR) domains similar to those of SLIT proteins (see SLIT1; MIM 603742). Most SLITRKs, including SLITRK5, also have C-terminal regions that share homology with neurotrophin receptors (see NTRK1; MIM 191315). SLITRKs are expressed predominantly in neural tissues and have neurite-modulating activity (Aruga et al., 2003 [PubMed 14557068]).[supplied by OMIM, Mar 2008]
PHENOTYPE: Mice homozygous for a null allele have abnormal medium spiny neuron morphology and exhibit behavioral abnormalities. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Slitrk5||
(F):5'- TTGGGGATCTAGGCAACCTGAGAC -3'
(R):5'- GGGCATAGCAGTTCAGACTTGATGG -3'
(F):5'- CTGAGACGCCTCTATCTGAATGG -3'
(R):5'- AGTTCAGACTTGATGGACCGC -3'